I. TITLE “Generoso Pharmaceuticals & Chemicals‚ Inc.” II. POINT OF VIEW David Generoso‚ President (GPC)‚ a salesman III. BACKGROUND David Generoso could feel his “five-year itch” once more. He already had behind him 15 years of experience in the pharmaceutical industry and was managing an interesting portfolio of businesses revolving around pharmaceutical and chemical products. Still‚ he felt he had not exhausted the opportunities had to offer. David began his career in the Philippine
Premium
Pharmaceutical industry in India From Wikipedia‚ the free encyclopedia The Pharmaceutical industry in India is the world’s third-largest in terms of volume.[1] According to Department of Pharmaceuticals of the Indian Ministry of Chemicals and Fertilizers‚ the total turnover of India’s pharmaceuticals industry between 2008 and September 2009 was US$21.04 billion.[2] While the domestic market was worth US$12.26 billion. The industry holds a market share of $14 billion in the United States. [3] According
Premium Pharmaceutical industry Pharmacology Generic drug
Cooper Pharmaceuticals Inc BMKT 436: Sales and Sales Management Shaye Murphy 10/12/2013 Executive Summary Goals Cooper Pharmaceuticals Inc (CPI) is a major manufacturer for the dental and medical practices in the United States. Their ultimate goal is to remain the largest drug manufacturer and meet the sales quotas. CPI has strong ethical policies that they want to keep that have shaped the companies’ reputation. In hiring Bob Marsh‚ they were meeting their goals
Premium Sales Customer service Marketing
Incumbent Company: Dr. Reddy’s Laboratories ¬¬¬ Indian Pharmaceutical Industry can be valued at around $20billion (2009). By Volume‚ India is world’s second largest producer of pharmaceuticals‚ while by value it is world’s thirteenth largest. It is expected to grow at CAGR of 12% for 2010-2012 (global average 6%).Around 95% of Domestic demand is catered by Indian Pharmaceutical companies. In Indian Pharmaceuticals Market‚ Formulations accounted for 65% while Bulk Drugs accounted for 35% by
Premium Generic drug Pharmaceutical industry Pharmacology
CPI Case Bob Marsh a pharmacy manager takes a job with Cooper Pharmaceuticals and has an illustrious 12 year career with them. Throughout his career and especially towards the end Bob was conflicted with doing what was best for his customers and satisfying management. Every year management would do performance evaluations measuring how the salesman’s sales volume was and how his/her relationship improved with the physicians they try to sell to. Bob was always hitting or exceeding quota and had
Premium Management Sales
Questions for Review 1. Pharmaceutical companies do have a responsibility to distribute drugs for a low cost in developing and poorer countries. Africa’s GDP‚ and per capita income is very low so they cannot afford to buy top quality medicines. One main argument for this approach is the AIDS epidemic in Africa. A main argument against this is that the treatment for AIDS is very expensive to provide to a whole country for free. 2. The principal arguments of pharmaceutical companies that oppose making
Premium HIV World Trade Organization Pharmacology
because of the following reasons: (1) Americans unjustly pay up to 5 times more to fill their prescriptions than consumers in other countries; (2) The United States is the largest market for pharmaceuticals in the world‚ yet American consumers pay the highest prices for brand pharmaceuticals in the world; (3) A prescription drug is neither safe nor effective to an individual who cannot afford it; (4) Allowing and structuring the importation of prescription drugs to ensure access to
Free Pharmacology
Case Study: Flower Pharmaceuticals A. The table below lists each category and states whether the cost is relevant‚ if it is an implicit or explicit cost‚ and if the cost has been properly calculated (note: company is currently operating at 65% capacity). Cost category | Relevant | Implicit/Explicit | Calculated correctly? | Fully allocated capital cost1 | N | Explicit | Y | Direct labor cost2 | Y | Explicit | Y | Materials Purchased3 | Y | Explicit | Y | Materials Inventoried4
Premium Costs Economics terminology Economics
for 10 ounce bottles of Linatol Introduction Lorex Pharmaceuticals recently gained FDA approval to market and sell a new product called Linatol. This memo will address the need to select a target amount to which each 10-ounce bottle of Linatol will be filled. The analysis of several target fill rates was conducted to determine the one that maximizes the contribution per case‚ therefore generating the maximum revenue for Lorex Pharmaceuticals. This ideal fill rate will allow more bottles to be
Premium Pharmaceutical drug Mathematics Cost
I. General Principles of Health Care Sickness - has been one of man’s greatest adversaries Medicine - Latin word “medicus” - it is a HEALING ART - Aims to help people become more active‚ live longer‚ live happier lives with less suffering and disability. - has become a part of the health care industry * AT THE TURN OF THE 20th CENTURY (1900): - men and women were frail at the age of 40. - life expectancy was 47.3 years. * BY THE AND OF THE 20th CENTURY: - Medical Advances - Life expectancy
Premium Health care Health care provider Medicine